Merck KGaA bets on cancer drugs to revitalize German firm

TEL AVIV (Reuters) - Merck KGaA is betting on its oncology pipeline to revitalize the German drugmaker as it sees falling sales from its best-selling medicine, multiple sclerosis treatment Rebif.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news